交易中 10-02 11:09:58 美东时间
-0.220
-0.99%
今日重点评级关注:Ascendiant Capital:维持GRI Bio"买入"评级,目标价从34美元升至35美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从7.5美元升至7.75美元
09-23 09:52
Raymond James analyst Aaron Kessler downgrades EverQuote (NASDAQ:EVER) from Strong Buy to Outperform and lowers the price target from $35 to $30.
09-23 00:28
Raymond James reshuffled its rating recommendations on a few insurance companies in the run-up to Q3 earnings season, upgrading Old Republic (NYSE:ORI) to Strong Buy from Outperform and downgrading Ev...
09-22 23:08
Oruka Therapeutics (NASDAQ:ORKA) added ~20% in the premarket on Wednesday after the company posted interim data from a Phase 1 trial for its lead asset ORKA-001, noting that the experimental therapy o...
09-17 20:46
EverCommerce has acquired ZyraTalk, an AI-powered customer engagement platform, to enhance its EverPro field service management solutions. The acquisition aims to improve customer experience, boost efficiency, and drive growth for service-based businesses. ZyraTalk’s 24/7 virtual assistant capabilities and automation workflows will integrate into EverCommerce’s ecosystem, benefiting over 725,000 service providers. The deal strengthens EverCommerc...
09-15 20:15
Evergold Corp ( ($TSE:EVER) ) just unveiled an announcement. Evergold Corp. ann...
09-15 19:57
(来源:氨基观察) BTK抑制剂的故事,正翻开新的一章 过去十年,伊布替尼、泽布替尼等凭借对B细胞通路的精准阻断,彻底改变了CLL、MCL等血液瘤的治疗格局...
09-08 10:51
9月2日,亚翔集成(603929)公告称,股东EVERCREATIVE计划以集中竞价方式减持公司股份不超过1,162,000股,占公司总股本的0.5446%。减持期间为公告之日起15个交易日后的3个月内。减持价格将按照市场价格,持股5%以上减持时须提前三个交易日进行公告。
09-02 11:30
The Trump administration is pushing forward with trade negotiations even after a U.S. appeals court ruled that most of President Donald Trump’s tariffs are unlawful, U.S. Trade Representative Jamieson...
08-31 23:49